Latest: Watch here for details of new products and services.
- Our Products
- Overview
- Partnering Search
- Company Profiling
- Partneringtools
- Reports
- Partnering Consulting
- Comparison
- Forums
- Visit our forums
- Jobs
- Visit our job site
- Case Studies
- See what others think about our service
- Newsletter
- Partnering update
- Key reports
- Subscribe
- Quick Links
- Profile now
- Register now
- Profiled companies
- Featured events
- Industry news
- PR Newswire New!
- Contact us
- Send an email
- Call us: +44 1904 520460
- Request a callback
- RSS Feeds
- Keep up to date
Pharmalicensing Ltd
is a division of
is a division of
Up-to-date access to technology licensing opportunities worldwide.
- In-licensing
- Browse
Licensing opportunities
Seeking late stage or currently marketed assets. More
LFB is seeking partners/companies which are looking for a strategic partnership to give them privileged access to hospital markets in Europe, ideally having a synergistic presence in North America or South East Asia. More
Seeking licensing opportunities for hospital pharmaceutical products in the UK and Ireland More
Are you a small to medium company seeking a UK presence? More
Astellas Pharma Taiwan wishes to in-license branded ethical drugs for the Taiwanese market More
Novel, late stage therapeutics are sought for marketing through a Europe wide specialist sales force. More
Strategic divestments of primary care sales focussed brands More
Fannin Limited has grown through the licensing and distribution of pharmaceutical products in the UK and Irish markets. We wish to talk to any company that may be thinking of rationalising their product portfolio. More
LFB is looking for alliances or in-licensing opportunities as the European arm for products ready to market or under clinical development, addressing severe diseases treated in hospitals. More
UK partner for strategic divestments More
Your selection
Browse By
- Industry sector
- Generics
- Nutrition
- OTC/Non-Prescription
- Pediatric
- Personal Care
- Prescription
- Therapeutic target
- Adoptive immunotherapy
- Amyloidosis
- Autoimmune disease (non-specific)
- Chronic fatigue syndrome
- Chronic granulomatous disease
- Chronic immunosuppression
- Gout
- Graft versus host disease
- HIV/AIDS
- Immune disorder (non-specific)
- Immune thrombocytopenic purpura
- Immunomodulation
- Immunostimulation
- Immunosuppression
- Lupus erythematosis
- Myalgic encephalomyelitis
- Myasthenia gravis
- Neoplastic disease
- Organ transplant rejection
- Rheumatoid arthritis
- Servere combined immunodeficency
- Sjogren's syndrome
- Systemic sclerosis
- Transplant rejection
- Xenotransplantation
- Development phase
- Early Stage
- Preclinical
- Phase I
- Phase I/II
- Phase II
- Phase III
- Phase III/IV
- Preregistration
- Registered
© Copyright 1995-2008 Pharmalicensing Ltd, is a division of 
All rights reserved. Terms and Conditions | Site map | Contact us